Pulsed Electromagnetic Energy to Ocular Tissue for Systemic Therapy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing treatments for various diseases and disorders are often unsatisfactory due to their complexity, individualistic nature, and adverse side effects, failing to effectively enhance or restore biological structures and functions, particularly in chronic and progressive diseases where the underlying cause is unknown.

Innovation Solution

Delivering pulsed electromagnetic energy, specifically pulsed low-level laser/light therapy (LLLT), to ocular tissues, particularly ocular blood vessels, stimulates the natural production of biological agents that provide remote therapeutic effects on non-ocular tissues and disorders, using precise energy parameters to avoid tissue damage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional treatments (gene therapy, drug therapy, anti-inflammatory treatments) are used to treat diseases, then some therapeutic effect is achieved, but adverse side effects and complications occur that make the treatment nearly as undesirable as the disease

Engineering Contradiction:
Improvetherapeutic effectivenessVSAvoidadverse side effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces conventional chemical and biological treatment mechanisms (drugs, gene therapy, immunosuppressive treatments) with a physical energy-based mechanism. Electromagnetic energy in the radiofrequency range is delivered to ocular tissue, which then generates endogenous biological responses throughout the body. This substitution eliminates the need for exogenous chemical agents that cause adverse side effects, while achieving therapeutic effects through controlled energy delivery and the body's own biological systems.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The treatment leverages the body's own natural healing and regulatory mechanisms. By delivering electromagnetic energy to ocular tissue, the system stimulates endogenous production of biological agents and activates the body's intrinsic ability to repair and regulate itself. This self-service approach avoids the need for external chemical interventions and their associated side effects, allowing the body to treat itself using its own resources and mechanisms.

Inventive Principle:
Principle #25Self-service

2Reliability

If treatments are designed to address individual genetic characteristics, then personalized therapeutic effectiveness is improved, but treatment complexity and resource requirements increase substantially

Engineering Contradiction:
Improveindividualized treatment effectivenessVSAvoidtreatment system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent employs a universal treatment mechanism that addresses individual variations through a single platform. The electromagnetic energy delivery system to ocular tissue serves multiple functions: it stimulates endogenous biological responses, activates systemic healing mechanisms, and provides therapeutic effects across different disease types. This universal approach adapts to individual genetic characteristics without requiring complex customized treatment protocols or multiple different treatment modalities for different patients.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Productivity

If electromagnetic energy is delivered at high intensity to produce rapid therapeutic effects, then treatment speed is improved, but tissue damage and adverse effects occur

Engineering Contradiction:
Improvetreatment speedVSAvoidtissue damage
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent employs periodic or pulsed delivery of electromagnetic energy to ocular tissue. Rather than continuous high-intensity exposure, the energy is delivered in controlled pulses or periodic intervals. This periodic action allows tissue to respond and recover between pulses, preventing thermal damage and adverse effects while maintaining therapeutic effectiveness. The pulsed regime enables sustained treatment over time without accumulating harmful effects.

Inventive Principle:
Principle #19Periodic action

Solution Approach 2:

The treatment utilizes controlled changes in electromagnetic energy parameters (frequency, power, duration, pulse width) to optimize therapeutic effects while avoiding tissue damage. By adjusting these parameters within specific ranges and maintaining them below damage thresholds, the system achieves productive treatment speed without causing harmful effects. The parameters are carefully selected and maintained to produce beneficial biological responses while preventing thermal or mechanical damage to ocular and systemic tissues.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The treatment enhances the body's natural healing processes, providing effective and well-tolerated benefits for non-ocular diseases and disorders without significant adverse side effects, including stimulating the production of beneficial biological agents that circulate and treat conditions such as cancer, heart disease, neurodegenerative disorders, and metabolic disorders.

Implementation Method 1

delivering pulsed electromagnetic energy to ocular tissue, which has a beneficial remote therapeutic effect on a non-ocular tissue

Methodology Applied
Scientific EffectElectromagnetic energy stimulation:

Implementation Method 2

delivering pulsed electromagnetic energy to at least one ocular blood vessel of the patient

Methodology Applied
Scientific EffectPhotobiomodulation:

Data Source

PatentUS12409336B2Treatment of non-ocular diseases/disorders by delivery of electromagnetic energy to ocular tissue
Publication Date: 2025.09.09 PON DAVID
  • US12409336B2 patent drawing
  • US12409336B2 patent drawing

AI summary

A process that provides preventative, protective and therapeutic treatment for non-ocular biological tissues or fluids includes applying a pulsed energy source to an ocular tissue or a target fluid to therapeutically or prophylactically treat the non-ocular tissue or fluid. A pulsed energy source having selected energy parameters may be applied to one or more ocular blood vessel of an individual who has a non-ocular disease/disorder. In accordance with one aspect of the present disclosure, it is determined that an individual has one or more non-ocular disease/disorder or other degenerative disease or is at a risk of developing such a disease, and pulsed electromagnetic energy is applied to an ocular tissue of the individual to therapeutically or prophylactically treat the non-ocular disease/disorder.